Nucor heads into the back half of May with a sharp divergence between what analysts are saying and what executives are doing with their own shares.
The analyst pivot is the standout story this week. After a strong Q1 print, the Street moved in near-unison to lift price targets. JP Morgan raised its target from $212 to $240, Citigroup made the boldest move — lifting from $180 to $260 — and Wells Fargo pushed to $244. BMO followed with a raise to $235. The consensus mean now sits at $240.70, roughly 6% above the current $227 close. UBS was the lone dissenter, downgrading to Neutral while still raising its target to $224 — a sign that at least one major house sees the re-rating as largely done. The overall direction is constructive, but the message from the most bullish firms is already priced into a stock that has rallied 19% over the past month.
Options positioning adds a layer of defensiveness to that bullish analyst tone. Demand for puts has risen relative to calls, with the put/call ratio climbing to 0.72 — about 1.5 standard deviations above its 20-day average of 0.61. That's not an extreme reading, but it does mark a clear shift since late April, when the PCR was running in the low-to-mid 0.50s. Options traders are hedging more than they were just two weeks ago, even as the stock absorbed most of its post-earnings gains. The 52-week low on the PCR is 0.38; the current level is more than halfway toward the high of 0.91.
Short positioning tells a quieter story. SI % of free float is just under 2% — not a level that warrants much attention on its own. The figure ticked up roughly 4% over the week, but from a very low base. Borrow conditions remain easy: the cost to borrow is 0.42% annualised, and even with a 25% week-on-week uptick, that remains negligible. Availability is effectively unconstrained. There is no meaningful short-side pressure here.
The more interesting signal is inside the company itself. Multiple executives sold shares in early May. EVP Allen Behr cleared roughly $1.9 million on May 4. EVP Daniel Needham sold close to $2.9 million across two transactions on May 1. EVP Noah Hanners sold $1.47 million the same day, and COO David Sumoski added a smaller sale on April 30. The net insider position over 90 days is a net sale of around $18.5 million in value terms. The trades carry low individual significance scores, and they follow a sharp run-up in the stock, so routine profit-taking is the natural read. But the cluster of senior executives selling into the same week is worth noting against the backdrop of an analyst community raising targets.
Peer performance through the week adds context. Close peer STLD fell 2.5% on the week, RS dropped 2%, while TX was the hardest hit at nearly 9% lower — suggesting broad sector softness rather than a NUE-specific story. CMC managed a small gain of 0.4%, the outlier in an otherwise weak metals tape.
The next confirmed earnings event is July 30. With the stock trading near the mean analyst target and insiders having sold into the recent strength, the key question between now and then is whether the macro backdrop for steel demand — and the tariff environment that helped drive the April rally — holds steady enough to validate the Street's upgraded numbers.
See the live data behind this article on ORTEX.
Open NUE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
